CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale President and CEO sold 3,563 shares at $1.29 ($4,596)
- 4 Open-market sale President and CEO sold 3,573 shares at $1.30 ($4,645)
- 4 Open-market sale EVP & Chief Medical Officer sold 21,636 shares at an average $1.18 ($25,493)
- 4 Open-market sale EVP, Chief Development Officer sold 22,466 shares at an average $1.18 ($26,470)
- 4 Open-market sale EVP, CFO & Treasurer sold 33,849 shares at an average $1.18 ($39,788)
- 4 Open-market sale SVP, General Counsel&Secretary sold 20,549 shares at an average $1.18 ($24,150)
- 4 Open-market sale EVP & Chief Commercial Officer sold 26,949 shares at an average $1.18 ($31,684)
- 4 Open-market sale President and CEO sold 99,844 shares at an average $1.18 ($117,399)
- 4 Grant or award EVP & Chief Medical Officer acquired 198,959 shares (grant or award)
- 4 Grant or award EVP, Chief Development Officer acquired 188,205 shares (grant or award)
- 4 Open-market sale EVP, CFO & Treasurer sold 2,545 shares at $1.32 ($3,369)
- 4 Grant or award SVP, General Counsel&Secretary acquired 147,000 shares (grant or award)
- 4 Grant or award EVP & Chief Commercial Officer acquired 198,959 shares (grant or award)
- 4 Grant or award President and CEO acquired 442,800 shares (grant or award)
- 4 Open-market sale EVP, Chief Development Officer sold 5,847 shares at an average $1.33 ($7,783)
- 4 Open-market sale EVP, CFO & Treasurer sold 4,205 shares at $1.59 ($6,671)
- 4 Open-market sale President and CEO sold 4,012 shares at $1.59 ($6,365)
- 4 Grant or award EVP & Chief Commercial Officer acquired 14,167 shares (grant or award)
- 4 Grant or award EVP & Chief Medical Officer acquired 14,167 shares (grant or award)
- 4 Grant or award EVP, Chief Development Officer acquired 13,333 shares (grant or award)
Page 6 of 31 · 601 filings